Radiolabelled MMP binding agents for the identification, quantification, and targeting of MMPs in central nervous system (CNS) disorders and tumours

由于人口老龄化，癌症和中枢神经系统疾病是澳大利亚面临的两大健康挑战。为了应对这些挑战，我们需要开发方法，利用非侵入性技术，在早期阶段识别肿瘤和中枢神经系统疾病，以便在最有可能奏效的时候应用治疗方法。在这个项目中，我们正在开发新的放射性标记化合物，这将使肿瘤、肿瘤转移和中枢神经系统疾病状态的成像成为可能。

Cancer and diseases of the central nervous system (CNS) represent two of the major health challenges facing Australia because of the aging population. In order to address these challenges we need to develop methods for identifying tumours and CNS diseases using non-invasive technologies and at an early stage so that treatments can be applied when they are most likely to work. In this project, we are developing new radiolabelled compounds that will enable the imaging of tumours, tumour metastases and CNS diseases states.